Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Assets (2016 - 2025)

Historic Assets for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $635.4 million.

  • AtriCure's Assets rose 331.25% to $635.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $635.4 million, marking a year-over-year increase of 331.25%. This contributed to the annual value of $609.3 million for FY2024, which is 74.99% down from last year.
  • AtriCure's Assets amounted to $635.4 million in Q3 2025, which was up 331.25% from $608.8 million recorded in Q2 2025.
  • AtriCure's Assets' 5-year high stood at $701.1 million during Q2 2021, with a 5-year trough of $581.9 million in Q3 2022.
  • Over the past 5 years, AtriCure's median Assets value was $600.3 million (recorded in 2023), while the average stood at $611.0 million.
  • In the last 5 years, AtriCure's Assets skyrocketed by 3262.4% in 2021 and then tumbled by 1641.93% in 2022.
  • Over the past 5 years, AtriCure's Assets (Quarter) stood at $615.3 million in 2021, then decreased by 4.85% to $585.4 million in 2022, then rose by 4.87% to $613.9 million in 2023, then fell by 0.75% to $609.3 million in 2024, then grew by 4.29% to $635.4 million in 2025.
  • Its Assets stands at $635.4 million for Q3 2025, versus $608.8 million for Q2 2025 and $591.6 million for Q1 2025.